Your browser doesn't support javascript.
loading
Five-year survival with nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma.
Uhara, Hisashi; Kiyohara, Yoshio; Uehara, Jiro; Fujisawa, Yasuhiro; Takenouchi, Tatsuya; Otsuka, Masaki; Uchi, Hiroshi; Fukushima, Satoshi; Minami, Hironobu; Hatsumichi, Masahiro; Yamazaki, Naoya.
Afiliação
  • Uhara H; Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Kiyohara Y; Dermatology Division, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Uehara J; Department of Dermatologic Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Fujisawa Y; Department of Dermatology, University of Tsukuba Hospital, Ibaraki, Japan.
  • Takenouchi T; Department of Dermatology, Niigata Cancer Center Hospital, Niigata, Japan.
  • Otsuka M; Dermatology Division, Shizuoka Cancer Center Hospital, Shizuoka, Japan.
  • Uchi H; Department of Dermato-Oncology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Fukushima S; Department of Dermatology and Plastic Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan.
  • Minami H; Department of Medical Oncology/Hematology, Kobe University Graduate School of Medicine, Hyogo, Japan.
  • Hatsumichi M; Ono Pharmaceutical Co., Ltd., Osaka, Japan.
  • Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
J Dermatol ; 48(5): 592-599, 2021 May.
Article em En | MEDLINE | ID: mdl-33715172

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão